SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma

Name: SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma
License: Public Domain

RTOG Foundation, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

head and neck squamous cell carcinoma (hnscc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 148743
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.